Pharmacists in Oak Grove, LA Accepting Medicare
6 Pharmacists found. Showing 1 - 6
 Jeanie Rye, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 705 S Constitution Ave, Oak Grove, LA 71263 Phone: 318-428-9641 Fax: 318-428-9277 |
Mrs. Ann Marie Nicole Moody, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 411 E Main St, P O Drawer 1003, Oak Grove, LA 71263 Phone: 318-428-4205 Fax: 318-428-4207 |
Pamela Lewis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 705 S Constitution Ave, Oak Grove, LA 71263 Phone: 318-428-9641 Fax: 318-428-9277 |
Brittany Strong Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 411 E Main St, Oak Grove, LA 71263 Phone: 318-428-4205 |
Mrs. Angela Thompson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 705 S Constitution Ave, Oak Grove, LA 71263 Phone: 318-428-9641 Fax: 318-428-9278 |
Dr. Laura Martin Perkins, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 803 E Main St, Oak Grove, LA 71263 Phone: 318-428-4344 Fax: 318-490-8004 |
News Archive
New study breaks the long-held idea that working memory has fixed limits
Breaking with the long-held idea that working memory has fixed limits, a new study by researchers at Uppsala University and New York University suggests that these limits adapt themselves to the task that one is performing. The results are presented in the scientific journal eLife.
New guidance may help minimize risks to patient privacy in clinical trials
New guidance published in the open access journal Trials and bmj.com this week sets out how personal information from clinical trials should be shared to help minimize risks to patient privacy.
Stone tools of Indonesian "hobbit" studied
A Southern Cross University researcher has begun the painstaking task of analysing hundreds of stone tools believed to have been used by the "hobbits" – a new species of miniature humans found on the Indonesian island of Flores.
Wilmot Cancer Center studies new chemo pill for lymphoma
Doctors at the University of Rochester's James P. Wilmot Cancer Center are first in the world to study a new, targeted agent that zeroes-in on B-cell lymphomas. The new twice-a-day pill offers patients with recurrent disease another choice as their options grow thin.
› Verified 8 days ago